What are ASPE's recent SEC filings?
8-K · OtherNov 2, 2026
Aspen Neuroscience completed its initial public offering of 9,375,000 shares of common stock at $15.00 per share, raising approximately $140.6 million in gross proceeds. In connection with the IPO closing, the company's amended and restated certificate of incorporation and bylaws became effective.
View full filing details →Gross proceeds from IPO: $140.6M, IPO price per share: $15, Number of shares sold in IPO: $9.4M
EFFECT · OtherOct 29, 2026
Aspen Neuroscience, Inc. filed an EFFECT notice with the SEC, indicating that a registration statement has been declared effective. The filing directory contains only index headers and a primary document XML, with no substantive details about the offering.
View full filing details →Has ASPE ever done a stock split?
No stock splits are recorded for ASPE.
Get Real-Time ASPE Intelligence
SEPT X-Ray combines SEC filings with price targets, support/resistance levels, and smart money tracking — updated every 30 minutes.
Try SEPT X-Ray Free